TRIVENI BIO
Triveni Bio is at the forefront of human genetics, cutting-edge antibody design, and precision medicine, pioneering the identification of new disease targets.
TRIVENI BIO
Social Links:
Industry:
Health Care Medical
Founded:
2019-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.triveni.bio
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
92 M USD
Technology used in webpage:
Cloudflare Hosting Person Schema Gravatar Profiles
Similar Organizations
Alphaeon
Alphaeon is a social commerce company with the goal of transforming self-pay healthcare.
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
BioAtla
BioAtla develops safer, more effective drugs for cancer using a proprietary next-generation antibody discovery and evolution platform.
DalCor Pharmaceuticals
DalCor is developing precision treatments for cardiovascular disease by genetically targeting patients that will derive clinical benefits
Peroxitech Therapeutics
Peroxitech Therapeutics operates as a biopharmaceutical company.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Vivodyne
Vivodyne develops an automated robotic system that discovers life-changing drugs and cellular therapies.
Current Advisors List
Current Employees Featured
Founder
Investors List
OrbiMed
OrbiMed investment in Series A - Triveni Bio
Atlas Venture
Atlas Venture investment in Series A - Triveni Bio
Viking Global Investors
Viking Global Investors investment in Series A - Triveni Bio
Invus
Invus investment in Series A - Triveni Bio
Polaris Partners
Polaris Partners investment in Series A - Triveni Bio
Cormorant Asset Management
Cormorant Asset Management investment in Series A - Triveni Bio
Alexandria Venture Investments
Alexandria Venture Investments investment in Series A - Triveni Bio
Key Employee Changes
| Date | New article |
|---|---|
| 2024-06-12 | Triveni Bio Appoints Bhaskar Srivastava, M.D., Ph.D., as Chief Medical Officer, Announces Key Program Updates |
Official Site Inspections
http://www.triveni.bio Semrush global rank: 8.1 M Semrush visits lastest month: 648
- Host name: 151.101.66.159
- IP address: 151.101.66.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Triveni Bio"
Triveni Bio 2025 Company Profile: Valuation, Funding …
How much funding has Triveni Bio raised over time? Triveni Bio has raised $232M. Who are Triveni Bio’s investors? Deep Track Capital, Fidelity …See details»
Triveni Bio - LinkedIn
Not only did proceeds from their auction support our organization but many team members and community members contributed personally as well. ... Triveni Bio is a biotech company pioneering a ...See details»
Triveni Bio - Crunchbase Company Profile & Funding
Triveni Bio is a biotech company advancing novel antibody treatments for I&I disorders. Using a genetics-driven precision medicine approach, the company …See details»
Org Chart Triveni Bio - The Official Board
Organizational Chart of Triveni Bio. Triveni Bio triveni.bio. has 21 executives +1 781 622 1700; Add an executive. Triveni Bio News . Anything missing? We search for you. Print or download …See details»
Triveni Bio - The Org
Triveni Bio is a biotech company pioneering a genetics-informed precision medicine approach to develop functional antibodies for the treatment of I&I disorders. The company’s approach …See details»
Triveni Bio, Inc. Company Profile | Watertown, MA | Competitors ...
Find company research, competitor information, contact details & financial data for Triveni Bio, Inc. of Watertown, MA. Get the latest business insights from Dun & Bradstreet.See details»
Triveni Bio - VentureRadar
Triveni Bio is breaking new ground on the identification of novel disease targets – working at the convergence of human genetics, best-in-class antibody design, and precision medicine. We …See details»
Triveni Bio - Biotech Careers
Pioneering a Mendelian genetics-informed precision medicine approach to develop functional antibodies for the treatment of immunological and inflammatory (I&I) disorders. Their lead …See details»
Triveni emerges from biotech merger with $92M for …
Oct 26, 2023 Biotechnology company Triveni Bio launched Thursday with $92 million in Series A funding and a focus on what it calls “genetics-informed precision medicine” approach to immune and inflammatory diseases. The …See details»
Science and Pipeline | Triveni Bio
Triveni’s lead program, TRIV-509, is a half-life extended monoclonal antibody that contains an active site inhibitor of both KLK5/7. Through this mechanism in animal models, TRIV-509 has demonstrated the ability to directly impact each …See details»
Triveni Bio | VentureRadar
Triveni Bio is breaking new ground on the identification of novel disease targets – working at the convergence of human genetics, best-in-class antibody design, and precision medicine. We …See details»
Triveni Bio Welcomes Jeff Albers and Allison Luo to its ... - BioSpace
Dec 13, 2023 --Board expansion marks an important strategic step as Triveni advances precision I&I pipeline--WALTHAM, Mass., Dec. 13, 2023 /PRNewswire/ -- Triveni Bio Inc., a …See details»
Triveni Bio - Contacts, Employees, Board Members, Advisors
Organization. Triveni Bio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. Number of Board …See details»
TRIV-509 - Drug Targets, Indications, Patents - Synapse - Patsnap
Mar 20, 2025 About Triveni Bio Triveni Bio is a biotechnology company at the forefront of novel antibody-based therapies for immunological and inflammatory disorders. Using a genetics …See details»
Triveni Bio - Work in biotech
Triveni Bio is pioneering a genetics-informed precision medicine approach to develop functional antibodies for the treatment of immunological and inflammatory (I&I) disorders. The company's …See details»
Triveni Bio Raises $115 Million Series B Financing to Expand …
WATERTOWN, Mass., October 2, 2024 – Triveni Bio Inc., a biotech company advancing novel antibody treatments for I&I disorders, today announced a $115 million Series B to support …See details»
Triveni Bio Welcomes Jeff Albers and Allison Luo to its Board of …
Dec 13, 2023 –Board expansion marks an important strategic step as Triveni advances precision I&I pipeline– WALTHAM, Mass., December 13, 2023 – Triveni Bio Inc., a biotech …See details»
Triveni Bio Launches with $92 Million Series A Financing to …
Oct 26, 2023 Triveni Bio’s lead antibody program (TRIV-509) targets kallikreins 5 and 7 (KLK5/7), promising targets for the treatment of atopic dermatitis, asthma, and other I&I …See details»
TriLink BioTechnologies® and the International Vaccine Institute …
1 day ago IVI, based in Seoul, Korea, is an autonomous international organization established in 1997 as an initiative of the United Nations Development Program. It is dedicated exclusively to …See details»
TriLink BioTechnologies® and the International Vaccine Institute …
1 day ago The International Vaccine Institute (IVI) is a non-profit international organization established in 1997 at the initiative of the United Nations Development Programme with a …See details»